IVNov 17, 2022
Bayesian Optimization of 2D Echocardiography SegmentationSon-Tung Tran, Joshua V. Stough, Xiaoyan Zhang et al.
Bayesian Optimization (BO) is a well-studied hyperparameter tuning technique that is more efficient than grid search for high-cost, high-parameter machine learning problems. Echocardiography is a ubiquitous modality for evaluating heart structure and function in cardiology. In this work, we use BO to optimize the architectural and training-related hyperparameters of a previously published deep fully convolutional neural network model for multi-structure segmentation in echocardiography. In a fair comparison, the resulting model outperforms this recent state-of-the-art on the annotated CAMUS dataset in both apical two- and four-chamber echo views. We report mean Dice overlaps of 0.95, 0.96, and 0.93 on left ventricular (LV) endocardium, LV epicardium, and left atrium respectively. We also observe significant improvement in derived clinical indices, including smaller median absolute errors for LV end-diastolic volume (4.9mL vs. 6.7), end-systolic volume (3.1mL vs. 5.2), and ejection fraction (2.6% vs. 3.7); and much tighter limits of agreement, which were already within inter-rater variability for non-contrast echo. These results demonstrate the benefits of BO for echocardiography segmentation over a recent state-of-the-art framework, although validation using large-scale independent clinical data is required.
LGJan 23, 2019
A Large-scale Multimodal Study for Predicting Mortality Risk Using Minimal and Low Parameter Models and Separable Risk AssessmentAlvaro E. Ulloa Cerna, Marios Pattichis, David P. vanMaanen et al.
The majority of biomedical studies use limited datasets that may not generalize over large heterogeneous datasets that have been collected over several decades. The current paper develops and validates several multimodal models that can predict 1-year mortality based on a massive clinical dataset. Our focus on predicting 1-year mortality can provide a sense of urgency to the patients. Using the largest dataset of its kind, the paper considers the development and validation of multimodal models based on 25,137,015 videos associated with 699,822 echocardiography studies from 316,125 patients, and 2,922,990 8-lead electrocardiogram (ECG) traces from 631,353 patients. Our models allow us to assess the contribution of individual factors and modalities to the overall risk. Our approach allows us to develop extremely low-parameter models that use optimized feature selection based on feature importance. Based on available clinical information, we construct a family of models that are made available in the DISIML package. Overall, performance ranges from an AUC of 0.72 with just ten parameters to an AUC of 0.89 with under 105k for the full multimodal model. The proposed approach represents a modular neural network framework that can provide insights into global risk trends and guide therapies for reducing mortality risk.